25 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp02326 | Cecropin A | KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK | Silkmoth | Membrane disruption | WST-1 assay | 486P | Bladder cancer | IC50 : 251.47 µg/ml |
| dbacp02327 | Cecropin A | KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK | Silkmoth | Membrane disruption | WST-1 assay | RT4 | Bladder cancer | IC50 : 231.26 µg/ml |
| dbacp02328 | Cecropin A | KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK | Silkmoth | Membrane disruption | WST-1 assay | 647V | Bladder cancer | IC50 : 185.39 µg/ml |
| dbacp02329 | Cecropin A | KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK | Silkmoth | Membrane disruption | WST-1 assay | J82 | Bladder cancer | IC50 : 212.07 µg/ml |
| dbacp02330 | Cecropin A | KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK | Silkmoth | Membrane disruption | Cell viability assay | 486P | Bladder cancer | IC50 : 69.2 µg/ml |
| dbacp02331 | Cecropin A | KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK | Silkmoth | Membrane disruption | Cell viability assay | RT4 | Bladder cancer | IC50 : 96.22 µg/ml |
| dbacp02332 | Cecropin A | KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK | Silkmoth | Membrane disruption | Cell viability assay | 647V | Bladder cancer | IC50 : 28.74 µg/ml |
| dbacp02333 | Cecropin A | KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK | Silkmoth | Membrane disruption | Cell viability assay | J82 | Bladder cancer | IC50 : 99.01 µg/ml |
| dbacp02334 | Cecropin A | KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK | Silkmoth | Membrane disruption | LDH leakage assay | 486P | Bladder cancer | IC50 : 373.3/ µg/ml |
| dbacp02335 | Cecropin A | KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK | Silkmoth | Membrane disruption | LDH leakage assay | RT4 | Bladder cancer | IC50 : 289.3 µg/ml |
| dbacp02336 | Cecropin A | KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK | Silkmoth | Membrane disruption | LDH leakage assay | 647V | Bladder cancer | IC50 : 200.7 µg/ml |
| dbacp02337 | Cecropin A | KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK | Silkmoth | Membrane disruption | LDH leakage assay | J82 | Bladder cancer | IC50 : 319.2 µg/ml |
| dbacp02357 | Cecropin B | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL | Silkmoth | Pore formation at the cytoplasmic membrane | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : 15.5 µM |
| dbacp02358 | Cecropin B | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL | Silkmoth | Pore formation at the cytoplasmic membrane | MTT/MTS assay | BTS-30 | Breast cancer | IC50 : 24.8 µM |
| dbacp02359 | Cecropin B | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL | Silkmoth | Pore formation at the cytoplasmic membrane | MTT/MTS assay | HRT-18 | Colon cancer | IC50 : 25.5 µM |
| dbacp02360 | Cecropin B | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL | Silkmoth | Pore formation at the cytoplasmic membrane | MTT/MTS assay | DLD-1 | Colon cancer | IC50 : >100 µM |
| dbacp02361 | Cecropin B | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL | Silkmoth | Pore formation at the cytoplasmic membrane | MTT/MTS assay | WEHI-3B | Leukemia cancer | IC50 : 4.4 µM |
| dbacp02362 | Cecropin B | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL | Silkmoth | Pore formation at the cytoplasmic membrane | MTT/MTS assay | A-2780 | Ovarian cancer | IC50 : 30.6 µM |
| dbacp02363 | Cecropin B | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL | Silkmoth | Pore formation at the cytoplasmic membrane | MTT/MTS assay | HCLO | Colon cancer | IC50 : 33.5 µM |
| dbacp02364 | Cecropin B | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL | Silkmoth | Pore formation at the cytoplasmic membrane | MTT/MTS assay | CHO-KI | Ovarian cancer | IC50 : 32 µM |
| dbacp02365 | Cecropin B | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL | Silkmoth | Pore formation at the cytoplasmic membrane | MTT/MTS assay | MAC15A | Colon cancer | IC50 : 37 µM |
| dbacp02366 | Cecropin B | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL | Silkmoth | Pore formation at the cytoplasmic membrane | MTT/MTS assay | MCF-7 | Breast cancer | IC50 : 42.5 µM |
| dbacp02367 | Cecropin B | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL | Silkmoth | Pore formation at the cytoplasmic membrane | MTT/MTS assay | HT-29 | Colon cancer | IC50 : >100 µM |
| dbacp02368 | Cecropin B | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL | Silkmoth | Pore formation at the cytoplasmic membrane | MTT/MTS assay | A-2780R | Ovarian cancer | IC50 : 34.5 µM |
| dbacp02369 | Cecropin B | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL | Silkmoth | Pore formation at the cytoplasmic membrane | MTT/MTS assay | MCF-7R | Breast cancer | IC50 : 24.5 µM |